Every tablet of ACERIV-200 SR is manufactured in our WHO-GMP and ISO 9001:2015 certified facility using advanced sustained-release matrix technology — ensuring 12 hours of consistent pain relief with proven bioequivalence.
How Our Sustained-Release Technology Works
Unlike conventional Aceclofenac tablets that release the drug immediately, ACERIV-200 SR uses a hydrophilic matrix system that gradually releases 200mg of Aceclofenac over 12 hours. This provides consistent plasma drug levels, reducing peak-related side effects and improving patient compliance with once-daily dosing.
Every batch undergoes rigorous 6-stage quality testing — from raw material identity verification through dissolution profiling, content uniformity, hardness testing, stability analysis, and final microbiological clearance. We use premium-grade raw materials sourced exclusively from USFDA-approved and WHO-GMP certified suppliers.
Franchise & Distribution Opportunity
ACERIV-200 SR is one of our flagship products with proven market demand across orthopedic and pain management segments. Franchise partners receive exclusive monopoly rights in their territory, competitive pricing with margins up to 30%, and complete promotional support — including visual aids, product literature, LBLs, MR bags, and branded gifts.
Our dedicated franchise support team provides regular product training, market insights, and prompt order fulfillment. With flexible MOQs starting as low as ₹10,000 and pan-India logistics, starting your pharma business with ACERIV-200 SR is a low-risk, high-return opportunity.
Third-Party & Contract Manufacturing
Need Aceclofenac 200mg SR tablets under your own brand? Our third-party manufacturing service covers end-to-end production — from formulation development and raw material sourcing to manufacturing, quality testing, and custom packaging with your branding. Minimum order quantities are flexible, delivery timelines are guaranteed, and all products come with full batch documentation and stability data.